BLENREP vs MOZOBIL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. BLENREP and MOZOBIL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BLENREP	MOZOBIL
Rating	70/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	BELANTAMAB MAFODOTIN-BLMF	PLERIXAFOR
Manufacturer	Glaxosmithkline	Genzyme
Dosage forms	Injectable	Injectable
Drug class	—	Hematopoietic Stem Cell Mobilizer
Boxed warning	Boxed warning	None
Treats	Multiple Myeloma	Non-Hodgkin Lymphoma, Multiple Myeloma

blenrep mozobil

Rating

70/100

Pharmacy pays

—

Type

Active ingredient

BELANTAMAB MAFODOTIN-BLMF

PLERIXAFOR

Manufacturer

Glaxosmithkline

Genzyme

Dosage forms

Injectable

Drug class

—

Hematopoietic Stem Cell Mobilizer

Boxed warning

None

Treats

Multiple Myeloma

Non-Hodgkin Lymphoma, Multiple Myeloma

Frequently asked questions

Which is better-rated, Blenrep or Mozobil?

Blenrep and Mozobil are tied at 3.5 out of 5 by our independent rating.

What is the difference between Blenrep and Mozobil?

Blenrep contains Belantamab Mafodotin-Blmf, while Mozobil contains Plerixafor — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.